Sorry, the video which you have requested is not yet processed.

Filter By:
13:47
In this "Best of the Day" presentation from ESMO 2014, Dr. Javier Cortes reviews the latest advances, clinical trial updates, and late-breaking news presented during this year's Breast Cancer sessions. Highlights include: final overall survival data from the phase III CLEOPATRA trial for patients with HER2 metastatic breast cancer; update...
by:imedex | 10 views
22:16
In this "Best of the Day" interview from ESMO 2014, Dr. Axel Grothey is joined by Dr. Florian Lordick to review the latest advances, clinical trial updates, and late-breaking news presented during this year's GI Malignancies sessions. Discussion highlights include: new and emerging therapies for gastric, pancreatic, and colorectal cancers...
by:imedex | 6 views
20:25
In this "Best of the Day" interview from ESMO 2014, Dr. Axel Grothey is joined by Dr. Caroline Robert to review the latest advances, clinical trial updates, and late-breaking news presented during this year's Melanoma sessions. Discussion highlights include: an overview of anti-PD-1/PD-L1 antibodies approved or in development; emerging th...
by:imedex | 4 views
22:33
In this "Best of the Day" interview from ESMO 2014, Dr. Axel Grothey is joined by Dr. Ramaswamy Govindan to review the latest advances, clinical trial updates, and late-breaking news presented during this year's Thoracic Oncology sessions. Discussion highlights include: new therapies on the horizon for ALK-positive lung cancer; updates on...
by:imedex | 3 views
17:11
In this "Best of the Day" interview from ESMO 2014, Dr. Ramaswamy Govindan is joined by Dr. Cora Sternberg to review the latest advances, clinical trial updates, and late-breaking news presented during this year's Genitourinary Cancer sessions. Discussion highlights include: practice-changi​ng results from the CHAARTED prostate cancer tria...
by:imedex | 3 views
19:41
Polycythemia vera is the most common of the myeloproliferat​ive neoplasms characterized by elevated hematocrit, splenomegaly and increased thrombotic risk. Together these conditions result in significant symptom burden and a reduced quality of life for these patients. The recent identification of gen...
by:imedex | 3 views
17:54
Polycythemia vera is the most common of the myeloproliferat​ive neoplasms characterized by elevated hematocrit, splenomegaly and increased thrombotic risk. Together these conditions result in significant symptom burden and a reduced quality of life for these patients. The recent identification of gen...
by:imedex | 4 views
19:03
Polycythemia vera is the most common of the myeloproliferat​ive neoplasms characterized by elevated hematocrit, splenomegaly and increased thrombotic risk. Together these conditions result in significant symptom burden and a reduced quality of life for these patients. The recent identification of gen...
by:imedex | 3 views
04:25
How do you find an MPN specialist? What if you live far away from a specialist? Dr. Bart Scott from Seattle Cancer Care Alliance and Dr. David Snyder from City of Hope discuss how specialists can work closely with your community oncologist. Once you’ve met with a specialist, your local physician can work closely with their team to make sure you hav...
by:patientpower | 27 views
03:20
This animation provides a comprehensive overview of how BioZorb fits into modern breast cancer care.
by:FocalTherapeutics | 39 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)